Morgan Stanley (MS) concluded trading on Wednesday at a closing price of $132.52, with 6.17 million shares of worth about $817.65 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 4.02% during that period and on June 18, 2025 the price saw a gain of about 1.87%. Currently the company’s common shares owned by public are about 1.61B shares, out of which, 1.23B shares are available for trading.
Stock saw a price change of 0.54% in past 5 days and over the past one month there was a price change of 1.28%. Year-to-date (YTD), MS shares are showing a performance of 5.41% which increased to 38.76% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $90.94 but also hit the highest price of $142.03 during that period. The average intraday trading volume for Morgan Stanley shares is 7.03 million. The stock is currently trading 2.38% above its 20-day simple moving average (SMA20), while that difference is up 8.45% for SMA50 and it goes to 8.73% higher than SMA200.
Morgan Stanley (NYSE: MS) currently have 1.61B outstanding shares and institutions hold larger chunk of about 62.43% of that.
The stock has a current market capitalization of $212.60B and its 3Y-monthly beta is at 1.29. PE ratio of stock for trailing 12 months is 15.55, while it has posted earnings per share of $8.52 in the same period. Its PEG reads 1.87 while making debt-to-equity ratio of 3.87. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for MS, volatility over the week remained 1.67% while standing at 1.27% over the month.
Stock’s fiscal year EPS is expected to rise by 8.94% while it is estimated to increase by 7.35% in next year. EPS is likely to shrink at an annualized rate of 8.33% for next 5-years, compared to annual growth of 8.89% made by the stock over the past 5-years.
Coverage by Wells Fargo stated Morgan Stanley (MS) stock as an Equal weight in their note to investors on November 15, 2024, suggesting a price target of $142 for the stock. Stock get an Underweight rating from Wells Fargo on August 02, 2024.
